FolioLanternBeta

Scribe Therapeutics, Inc. (SCTX)

Insiders reported no open-market sales in the past 12 months.

Latest filing: Filed Jul 28 for a purchase from Jul 24 to Jul 28. Behzad Aghazadeh bought 58K shares ($1.3M). Filing

See who sold, why, and what they still hold